Published April 1, 2019
| Version final
Project deliverable
Open
Deliverable D3.5 Results of the in vitro testing of mixtures regarding liver toxicity and craniofacial malformation
Creators
- Luckert, C.1
- Lichtenstein, D.1
- Braeuning, A.1
- de Sousa, G.2
- Durinck, S.3
- Katsanou, E. S.4
- Konstantinidou, P.4
- Machera, K.4
- Milani, E. S.5
- Peijnenburg, A.6
- Rahmani, R.2
- Rajkovic, A.3
- Rijkers, D.6
- Spyropoulou, A.4
- Stamou, M.5
- Stoopen, G.6
- Sturla, S. J.5
- Wollscheid, B.5
- Zucchini‐Pascal, N.2
- Lampen, A.1
- Moretto, A.7
- di Renzo, F.7
- Kyriakopoulou, K.4
- Machera, K.4
- Metruccio, F.7
- Menegola, E.7
- Spyropoulou, A.4
- van der Ven, L.8
- 1. BfR
- 2. INRA
- 3. Ghent University
- 4. BPI
- 5. ETH Zurich
- 6. WFSR (RIKILT)
- 7. UMIL
- 8. RIVM
Description
This deliverable consists of two parts and provides an instruction on the EuroMix testing strategy for testing compounds grouped based on their Mode of action (MoA) and their mixtures regarding the liver specific endpoint steatosis (Part 1) and regarding the craniofacial malformation specific endpoint following the same approach (Part 2).
Files
Deliverable 3.5.pdf
Files
(944.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:a8262753997fcab86ebce04fd2c5ae8b
|
944.5 kB | Preview Download |